文献速递白内障与屈光手术角膜与眼表疾病

飞秒激光辅助与传统超声乳化治疗硬核白内障的随机对照试验

Randomized Controlled Trial Comparing Femtosecond Laser-Assisted with Conventional Phacoemulsification on Dense Cataracts.
PubMed 文献 · Am J Ophthalmol · 2021-03-01

在新加坡国立眼科中心开展的随机对照试验,纳入核混浊分级>5的硬核白内障患者93例,按2:1:1随机分为传统超声乳化组、飞秒激光600微米网格组和16段碎裂组。结果显示飞秒激光网格组的角膜内皮细胞丢失显著少于传统超声乳化组,但16段碎裂组无此优势,且各组有效超声乳化时间无显著差异。

要点

  • 飞秒激光600微米网格碎裂可显著减少硬核白内障超声乳化术后的角膜内皮细胞丢失。
  • 16段碎裂模式未显示角膜内皮保护优势,各组有效超声乳化时间无显著差异。
  • 核混浊>6级者的有效超声乳化时间显著高于核混浊<6级者。

核心结论

  • 飞秒激光600微米网格碎裂但非16段碎裂,可显著降低硬核白内障超声乳化过程中的平均角膜内皮细胞丢失。

研究设计与样本

  • 随机对照试验,纳入核混浊分级>5(LOCS III)的患者93例,按2:1:1随机分为传统超声乳化组48例、飞秒激光600微米网格组22例和16段碎裂组23例。
  • 排除不适合飞秒激光辅助、角膜内皮细胞计数<1500 cells/mm2或合并其他复杂性白内障的患者。
  • 使用Victus激光平台和原位超声乳化劈核技术,收集术前及术后1个月最佳矫正视力、内皮细胞计数、有效超声乳化时间和围手术期并发症。

关键数值与推荐

  • 核混浊分级采用LOCS III标准,纳入>5级者。
  • 角膜内皮细胞计数<1500 cells/mm2者排除。
  • 随机分组比例为传统超声乳化:飞秒激光网格:飞秒激光16段=2:1:1。

临床怎么用

  • 对硬核白内障(核混浊>5级)行超声乳化时,可考虑采用飞秒激光600微米网格碎裂以减轻角膜内皮损伤。
  • 16段碎裂模式在减少内皮细胞丢失方面未显示优于传统超声乳化。

局限性

  • 样本量有限(共93例),飞秒激光组样本量较小(22例和23例)。
  • 多数患者为华人(93.5%),外推需谨慎。
  • 仅报告术后1个月结果,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the benefit of femtosecond laser-assisted cataract surgery (FLACS) versus phacoemulsification (PE) and 2 fragmentation patterns in managing dense cataracts. DESIGN: Randomized controlled trial. METHODS: Patients with nuclear opacity (NO) grade >5 (Lens Opacities Classification System III) were enrolled at the Singapore National Eye Centre. Patients who were unsuitable for FLACS, whose corneal endothelial cell count (ECC) was <1,500 cells/mm2, or had cataracts with additional complexities were excluded from the study. Eyes were randomized to PE, 600 μm grid (FLACSg), or 16-segment fragmentation (FLACS16) in 2:1:1 ratio. The Victus (Bausch & Lomb) laser platform and in situ phacoemulsification chop technique was used. Data for patient demographics, preoperative, and 1 month postoperative best-corrected visual acuity (BCVA), ECC, effective phacoemulsification time (EPT), and perioperative complications were collected. Outcome measurements were the loss of ECC at 1 month and EPT. RESULTS: Ninety-three patients were randomized to PE (48), FLACSg (22), and FLACS16 (23). Majority were Chinese (87; 93.5%). Mean age was 74.3 ± 8.8 years of age. Cataracts were mostly graded as NO 5-6 (49; 61.3%). EPT among treatment arms was not different (P = .097, one-way ANOVA) but was significantly higher for NO >6 than NO <6 (P < .001, general linear model). ECC loss was significantly less in FLACSg than in PE (P = .018, Bonferroni correction). Mean 1-month postoperative LogMAR BCVA (0.23 ± 0.20) was significantly better than preoperative BCVA (1.02 ± 0.85; P < .001, paired t test) but not different between PE and FLACS. CONCLUSIONS: FLACSg but not FLACS16 significantly lowered the mean ECC loss during phacoemulsification in dense cataracts.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chee SP, Yang Y, Wong MHY, et al. Randomized Controlled Trial Comparing Femtosecond Laser-Assisted with Conventional Phacoemulsification on Dense Cataracts. Am J Ophthalmol. 2021. PMID: 33662301. doi:10.1016/j.ajo.2020.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。